Edition:
United States

Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

7.18USD
30 Sep 2016
Change (% chg)

$0.31 (+4.51%)
Prev Close
$6.87
Open
$7.02
Day's High
$7.20
Day's Low
$7.00
Volume
1,427,232
Avg. Vol
1,088,975
52-wk High
$7.31
52-wk Low
$2.61

Select another date:

Thu, Jul 28 2016

BRIEF-Agenus Q2 loss per share $0.33

* Agenus reports second quarter 2016 financial results and operational progress

BRIEF-Agenus' chief financial officer, C.Evan Ballantyne to resign

* On july 14, 2016, C. Evan Ballantyne, chief financial officer informed agenus of his intention to resign - sec filing

BRIEF-Agenus Inc starts phase 1/2 clinical trial of anti-GITR agonist antibody

* Expect to initiate additional clinical studies with antibodies and immuno-oncology leads from comprehensive pipeline in next twelve months

BRIEF-Agenus announces lead product candidate selection in Merck collaboration

* Agenus announces lead product candidate selection in its collaboration with Merck

BRIEF-Agenus reports Q1 loss per share $0.37

* Agenus reports first quarter 2016 financial results and operational progress

BRIEF-Agenus commences phase 1 clinical trial of antibody to treat solid tumors

* Agenus Commences Phase 1 Clinical Trial Of Its CTLA 4 checkpoint antibody to treat solid tumors

Select another date: